Skip to main content
. 2021 Dec 7;61(8):3390–3395. doi: 10.1093/rheumatology/keab910

Table 1.

Pregnancy characteristics and outcomes

All pregnancies Pregnancy after IA diagnosis Pregnancy before IA diagnosis P-value
Total number of pregnancies 897 220 677
1st pregnancy, n (%) 408 (45.48) 103 (46.82) 305 (45.05) P = 0.87
Year of pregnancy, mean (s.d.) 1990 (12.76) 1996 (12.96) 1989 (12.12) P ≤ 0.05
TTP, months (s.d.) 5.35 (9.59) 6.99 (11.79) 4.83 (8.71) P ≤ 0.05
Spontaneous pregnancies, n (%) 854 (95.21) 200 (90.91) 654 (96.60) P ≤ 0.05
Conceived by ART, n (%) 43 (4.79) 20 (9.09) 23 (3.40) P ≤ 0.05
Pregnancy duration, weeks (s.d.) 38.31 (4.06) 38.57 (3.22) 38.23 (4.30) P = 0.66
Paternal demographic characteristics
Paternal age at conception, mean (s.d.) 31.31 (5.72) 34.27 (6.08) 30.49 (5.34) P ≤ 0.05
Paternal age at conception >40 years, n (%) 78 (8.70) 53 (24.09) 25 (3.69) P ≤ 0.05
Paternal education higher than bachelor, n (%) 363 (40.47) 94 (42.73) 269 (39.73) P = 0.44
Paternal preconception exposure a
Paternal smoking exposure, n (%) 344 (38.39) 67 (30.59) 277 (40.92) P ≤ 0.05
Paternal alcohol exposure, n (%) 613 (68.42) 136 (62.10) 447 (70.46) P = 0.07
Paternal medication exposure, n (%) 150 (16.74) 110 (50.23) 40 (5.91) P ≤ 0.05
Paternal diagnosis of IA
Age at diagnosis IA, years (s.d.) 42.99 (12.65) 26.99 (7.85) 47.59 (9.69) P ≤ 0.05
Diagnosis RA, n (%) 451 (50.28) 82 (37.27) 369 (54.51) P ≤ 0.05
Diagnosis JIA, n (%) 15 (1.67) 15 (6.82) 0 (0.00)
Diagnosis AS, n (%) 181 (20.18) 75 (34.09) 106 (15.66) P ≤ 0.05
Diagnosis PsA, n (%) 286 (31.88) 68 (30.91) 218 (32.20) P = 0.72
Paternal fertility evaluation outcomes a
Fertility evaluation, n (%) 138 (15.38) 57 (25.91) 81 (11.96) P ≤ 0.05
Low sperm quality, n (%) 45 (5.02) 20 (35.09) 25 (30.85) P = 0.60
Maternal demographic characteristics
Maternal age at conception, mean (s.d.) 29.00 (5.00) 30.69 (5.16) 28.45 (4.83) P ≤ 0.05
Maternal age at conception >40 years, n (%) 10 (1.11) 5 (2.27) 5 (0.74) P = 0.06
Maternal preconceptiona and pregnancy exposure
Maternal preconception smoking exposure, n (%) 171 (19.08) 32 (14.61) 139 (20.53) P = 0.06
Maternal smoking exposure during pregnancy, n (%) 58 (6.47) 13 (5.94) 45 (6.65) P = 0.93
Maternal alcohol exposure, n (%) 329 (36.72) 73 (33.33) 256 (37.81) P = 0.31
Maternal alcohol exposure during pregnancy, n (%) 53 (5.92) 16 (7.31) 37 (5.47) P = 0.45
Maternal fertility evaluation outcomes b
Fertility evaluation, n (%) 116 (12.93) 40 (18.18) 76 (11.23) P ≤ 0.05
P = 0.07
Female infertility secondary to known cause,bn (%) 37 (31.90) 19 (47.50) 18 (57.89) P ≤ 0.05
Female infertility secondary to unknown cause, n (%) 11 (9.48) 6 (15.00) 5 (6.58) P ≤ 0.05
Pregnancy outcomes
Live births, n (%) 794 (88.52) 190 (86.36) 604 (89.22) P = 0.05
Miscarriage, n (%) 78 (8.70) 27 (12.27) 51 (7.53) P ≤ 0.05
Induced abortion, n (%)
Medical indication
Personal reasons
25 (2.78)
5 (20.00)
20 (80.00)
3 (1.36)
0 (0.00)
3 (100.00)
22 (3.25)
5 (22.73)
17 (77.27)
P = 0.13
Stillbirths, n (%) 6 (0.67) 0 (0.00) 6 (0.89) P = 0.16
Pregnancy outcomes related to maternal and neonatal morbidity c
Pre-term birth, n (%) 149 (16.61) 31 (14.09) 118 (17.43) P = 0.24
Hypertensive disorders (hypertension, pre/eclampsia), n (%) 41 (4.57) 8 (3.64) 33 (4.87) P = 0.45
Gestational diabetes mellitus, n (%) 11 (1.28) 2 (0.94) 9 (1.38) P = 0.62
Intrauterine growth restriction, n (%) 12 (1.34) 1 (0.45) 11 (1.65) P = 0.19
Maternal anaemia, n (%) 15 (1.67) 6 (2.73) 9 (1.33) P = 0.16
a

3 months before conception.

b

Endometriosis, fallopian tube obstruction, polycystic ovary syndrome, uterine abnormality, early menopause.

c

Maternal and neonatal morbidity reported for pregnancies ≥ 16 weeks of gestation (n = 806).

ART: assisted reproductive technology; IA: inflammatory arthritis; TTP: time to pregnancy.